z-logo
open-access-imgOpen Access
Central nervous system activity of first-line osimertinib in epidermal growth factor receptor-mutant advanced non-small cell lung cancer
Author(s) -
Chong Kin Liam
Publication year - 2019
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2018.12.68
Subject(s) - osimertinib , epidermal growth factor receptor , mutant , lung cancer , central nervous system , cancer research , epidermal growth factor , lung , biology , receptor , medicine , oncology , neuroscience , genetics , erlotinib , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom